Access To Medicine Foundation | Access to Medicine Foundation

ACCESS TO MEDICINE INDEX 2022

Featured insights

Discover the latest at the Foundation

Spotlight on the generics industry: New analysis looks at access efforts of 5 major companies

Five ways to ramp up access to essential diabetes products

Explore per sector

R&D-based pharma companies

We encourage them to make their products accessible.

Generic medicine manufacturers

We empower the industry to become more responsive.

Medical gas companies

We stimulate the industry to ensure availability for treatments and procedures.

Diagnostic companies

We forge partnerships to unlock the potential of diagnostics.

Vaccine manufacturers

We guide them to improve access to immunisation.

Resource centre

Explore our research reports and publications

Featured Key findings

More access plans and strategies to expand access to more products, but with limited breadth and depth

15 November 2022

Featured Research

The Methodology for the 2022 Access to Medicine Index

22 September 2021

Lack of access to medicine is a major driver of drug resistance. How can pharma take action?

27 October 2022

How companies compare

Learn more about how pharmaceutical companies perform in the Access to Medicine Index

Explore our cross-sector programmes

Antimicrobial resistance programme

Diabetes care programme

Events and engagements

SHARING OUR INSIGHTS TO HELP DRIVE CHANGE

Margo Warren to address access challenges at Grand Challenges Annual Meeting 2023

08 October 2023

Guest lecture on AMR at VU Amsterdam: Insights on access to medicine and responsible manufacturing

09 October 2023

Foundation to speak at Reproductive Health Supplies Coalition event in Ghana

16 October 2023

Foundation investor event: 2023 company profiles from Generic and Biosimilar Medicines Programme report

19 October 2023

Media coverage

Read more about our coverage in global media

Poor countries desperately need better access to generic medicines

15 February 2023

Framework to assess, nudge generic drug makers to expand access to products

15 February 2023